melanocyte physiology and pathophysiology by prof. torello lotti
DESCRIPTION
Presentation from the World Vitiligo Symposium 2011. Sponsored by the VR Foundation.TRANSCRIPT
Physiology and Pathophysiology of
Melanocytes
Torello Lotti, MD Professor of Dermatology and Venereology
Florence, Italy
Melanocytes are pigment-producing cells that originate from the dorsal portion of the closing neural tube in vertebrate embryos.
MELANOCYTES
MELANOCYTES AND PIGMENTATION PHYSIOLOGY
Pluripotent neural crest cell
Melanoblast migration and differentiation into melanocytes is influenced by a number of signaling molecules produced by neighboring cells that interact with their their specific cell surface receptors.
Wnt
Endothelin-3 (ET-3)
Stem Cell Factor (SCF), c-Kit-ligand
Bone morphogenetic factor (BMPs)
Hepatocyte growth factor (HGF)
Wnt Family 16 different secreted glycoproteins; Directs the maturation of pluripotent neural crest cell into melanoblasts
Wnt Frizzled receptor
Induction and
accumulation of
Β- catenin
Transcription of
Microphthalmia-assocciated
transcription factor (Mitf)
Induce the transcription of 3 key
enzyme in melanin synthesis:
- Tyrosinase;
- TRP-1;
- TRP-2.
MITF is central to Melanocyte viability and function
Waardenburg syndrome type 2A - different colored irises; - white forelock; - congenital cochlear deafness.
normal MITF activity is
completely lost in these
animals
usually MITF activity
is only partially lost
Endothelins Family
ET-1, ET-2, ET-3 EdnrA, EdnrB (receptor)
ET-3 + EdnrB: - required for survival, prolifeartion and migration of melanoblasts; - also affect the development of other neural crest cells. - exracutaneous symptomatology in type IV Waardenburg syndrome and in Hirschsrung syndrome.
Stem Cell Factor
SCF: expressed by keratinocytes
c-Kit (its receptor): expressed on melanoblasts
Drive melanoblasts to their final destination
Mutations of c-Kit or SCF:
melanoblast unable to migrate to the skin and/or survive there
PIEBALDISM
MELANOBLAST
Inner ear Cochlea
Choroid Ciliary body Iris
Leptomeninges
Skin and Hair Follicle
CUTANEOUS MELANOCYTES
Melanocyte density/mm2: 550-1200 (highest concentration in genitalia and face)
Epidermal melanin unit: one melanocyte surrounded by several keratynocites
Melanocytes syntesize melanine, stored in cyosolic organelles (melanosomes) transferred to keratinocytes through dendritic process.
Keratinocytes signals regulate epidermal melanocyte survival, dendricity, melanogenesis…
MELANIZATION
The synthesis and distribution of melanin in the epidermis (pigmentation) involves several step:
Transcription of proteins required to melanogenesis
Melanosome biogenesis
Sorting of melanogenic proteins into the melanosomes
Transport of melanosomes to the tips of melanocyte dendritic cells
Transfer of melanosomes to keratinocytes
Disruption in any of these events results in Hypopigmentation
Melanosome Biogenesis
Unique menbrane bound organelle (modified version of lysosomes?) in which melanin biosynthesis take place.
Eumelanosomes Pheomelanosomes
Eumelanin Pheomelanin
Melanosome Biogenesis
MELANIN BIOSYNTHESIS
Two types of melanin
Eumelanin Dark, brown/black
Pheomelanin Light, red/yellow
• Melanin provide protection against UV (280-400 nm)- induced DNA damage; • UV absorbed is converted into heat (less toxic form of energy).
Melanin and its intermediates can be harmful to melanocytes: ROS generation: DNA damage: melanoma
MELANOGENIC PROTEINS
Tyrosinase: Chromosome 11
OCULOCUTANEOUS ALBINISM TYPE I
Mutations (missense, nonsense frameshift, deletion):
• Synthesized in Endoplasmic reticulus • Glycosilation in Golgi apparatus • Packaged in endosomes • Fuse in melanosome stage II
Enzymes and proteins involved in melanosomal maturation
Tyrosinase-Related Proteins (TRP)
TRP-1: chromosome 9
- Same Tyrosinase maturation pathway - Tyrosinase activation/stabilization ? - Melanosome biogenesis ?
Mutations: OCULOCUTANEOUS ALBINISM TYPE III
TRP-2: chromosome 13
Microphtalmia-Associated Transcription Factor (Mitf)
• Master gene for melanocyte survival; • Key factor regulating transcription of melanogenic proteins: Tyrosinase, TRP-1, TRP-2. • 9 isoforms: Mitf-M (specific for melanocytes), -A, -B, -C, -D, -E, -H, -J and –Mc.
Mitf activity is induced by binding of SCF to c-Kit receptor and by cAMP-elevating agents such α-MSH.
Microphtalmia-Associated Transcription Factor (Mitf)
Mitf upregulate the expression of anti-apoptotic protein BCl2
Melanocyte survival
Mitf
G1 to S phase (Melanocyte proliferation)
Cdk2
+
+
p21
-/+
-
Role in melanocyte proliferation ?
Melanocortin Receptor (MCR)
Family of five related receptors (MC1-5R). MC1R: melanocytes
Polimorphisms within the MC1R gene are largely responsible for the different skin/hair color among different ethnic group.
α-MSH ACTH
MC1R
cAMP Mitf transcription
Eumelanin synthesis
Propiomelancortin (POMC) encodes α-MSH and other hormones
Both pituitary gland anf epidermal keratinocytes are able to synthesized POMC
UV light activates p53 in keratinocytes,
p53 induces expression of POMC in keratinocytes
UV light activates a cascade that results in elevated melanin synthesis and transport
The “THREE ENZYME THEORY” and the crucial role of 6BH4
3 enzymes, phenylalanine hydroxylase activity (PAH), tyrosine hydroxylase isoform I (THI) and tyrosinase, are crucial for the initiation of melanogenesis
Schallreuter KU et al. Regulation of melanogenesis – controversies and new concepts. Experimental Dermatology 2008;
17: 395–404.
6BH4 in turn acts as the essential electron donor for PAH to produce L-tyrosine from L-phenylalanine and for THI to convert l-tyrosine to L-DOPA. 6BH4 is an allosteric inhibitor of tyrosinase.
MELANIN BIOSYNTHESIS
Dessinioti C et al.A review of genetic disorders of hypopigmentation: Lessons learned from the biology of melanocytes.
Experimental Dermatology 2009; 18: 741–749.
MELANOCYTE DENDRITES
• Branching protoplasmatic process that interact with keratinocytes.
• Actin is a major structural component of dendrites;
• Several keratinocytes-derived factors (ET-1, NGF, PGE2, β-endorphin) play a role in melanocyte dendricity; • Integrins also play a role in dendrite formation.
MELANOSOME TRANSPORT (in Melanocyte)
Microtubules (arranged parallel to the long axis of the dendrite)
Microtubule-associated motor proteins: Kinesins (centrifugal movement) and Dyneins (Ccentripetal movement)
Other partecipants:
Rab27a Myosin-Va melanophilin
+
Mutated in Griscelli syndrome
MELANOSOME TRANSPORT (to Keratinocytes)
Several potential ways involved
Exocytosis
Cytophagocitosis (keratinocytes
phagocytose the tip of a melanocyte dendrite)
Fusion of plasma menbranes
Transfer by membrane vesicles
REGULATION OF MELANOCYTE FUNCTION
Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004
Hypomelanoses: Why ?
1. Loss or reduction of melanocytes; 2. Reduced melanine production from
melanocytes (altered tyrosinase activity, altered structure/activity of rough endoplasmic reticulum, lack of specific melanocyte receptors…);
3. Decreased melanine transfer from melanocytes to keratinocytes;
4. Primary disorder of keratinocytes.
Hypomelanoses
Normal
Albinism
Vitiligo
Functional defect in melanine synthesis
Localized loss / inactivation of melanocytes
Disorders of Melanin Synthesis
Dessinioti C et al.A review of genetic disorders of hypopigmentation: Lessons learned from the biology of melanocytes.
Experimental Dermatology 2009; 18: 741–749.
Disorders of Melanocyte Development and Migration
Disorders of Melanosome Formation and Transfer to Keratinocytes
Dessinioti C et al.A review of genetic disorders of hypopigmentation: Lessons learned from the biology of melanocytes.
Experimental Dermatology 2009; 18: 741–749.
VITILIGO ETIOPATHOGENESIS
NEURAL HYPOTHESIS AUTOIMMUNE HYPOTHESIS
AUTOCYTOTOXIC/ RADICALIC HYPOTHESIS
GENETIC PREDISPOSITION Autoimmune Susceptibility Locus (AIS1)
ECLECTIC HYPOTHESIS MELANOCYTORRAGY SYNERGISTIC THEORY
MELANOCYTE DESTRUCTION
Vitiligo etiopathogenesis
GENETIC PREDISPOSITION
Autoimmune Susceptibility Locus (AIS1)
AUTOIMMUNE
Umoral mechanism -Autoantibodies
Citotoxic mechanism – Cell mediated
METABOLIC
Hydrogen peroxide accumulation
Abnormal expression of Tyrosine-Related Protein -1
OTHERS
Viral hypothesis
Neuronal toxicity
Autoimmune Pathogenesis
Presence of “vitiligo antibodies” in patients;
Vitiligo is associated with several autoimmune disease (vitiligo is a syndrome, not a disease…): tyroiditis (up to 40%), diabetes type I (1-7%), autoimmune gastritis, autoimmune polyglandular syndromes, alopecia areata…;
Most effective therapies in inducing repigmentation have also immunosuppressive effects (i.e.corticosteroids, ultraviolet, cytotoxic drugs);
Immunotherapies for melanoma often cause vitiligo patches.
Autoimmune Pathogenesis
Ongenae K et al. Evidence for an Autoimmune Pathogenesis of Vitiligo. Pigment Cell Res 16: 90–100. 2003
Altered antioxidant and scavenger
mechanism
Increased activity of superoxide
dismutase
High levels of epidermic 7-BH4 and H2O2
Inhibition of enzyme function (phenylalanine-hydroxilase and tyrosinase) and abnormal expression of Tyrosinase
Related Protein-1 (TRP-1).
impaired melanine synthesis
Metabolic Pathogenesis
Vitiligo: what’s new in 2011
Melanocytes are completely absent in the depigmented epidermis
Nordlund JJ and Lerner AB – Arch Dermatol, 1982;118:5-8
Le Poole IC et Al. J Invest Dermatol, 1993;100:816-822
Vs.
Melanocytes are not completely absent in the depigmented epidermis
Bertosi KJ et Al. Eur J Dermatol 1998;8:95-97
Tobin DJ et Al. J Pathol 2000;191:407-416
Gottschalk GM, Kidson SH. Int J Dermatol. 2007;46(3):268-72
Vitiligo: what’s new in 2011
Melanocytes are not completely absent in the depigmented epidermis
Massi D. Histopathological and ultrastructural features of vitiligo. In: Lotti T & Hercogova J (Eds.) Vitiligo – Problems and solutions. Marcel Dekker Inc, New York 2004
Normal Skin Perilesional Skin Lesional Skin
Vitiligo: what’s new in 2011
Melanocytes are not completely absent in the depigmented epidermis
Comment: – A subpopulation of “resistant” epidermal melanocytes can persist independent of disease duration
– Repigmentation can always occur independent of disease duration and with non-perifollicular pattern
VITILIGO: NOT ONLY A MELANOCYTIC DISEASE?
Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004
Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004
What’s new in 2011: A focus on keratinocytes
Impaired scavenging mechanisms can lead to ROS increase and subsequent melanocyte and keratinocyte damaging;
Altered function of PAR-2 receptor can impair calcium homeostasis in keratinocytes and alter melanosome intake and processing.
What’s new in 2011: the focus on keratinocytes
The importance in mitochondria in keratinocytes from perilesional skin and the role of oxidative stress.
Prignano F, et al. Ultrastructural and functional alterations
of mitochondria in perilesional vitiligo skin. J Derm Sci
2009;54:157–167
Mitochondrial alterations in perilesional keratinocytes
Mitochondrial activity plays a crucial role in normal cell function
Mitochondrial alterations observed in perilesional keratinocytes appear to be very similar to those described in the same cell types during apoptosis
The mitochondrial damage is associated with an increase in ROS production and, hence, oxidative stress.
Prignano F, et al. J Derm Sci 2009;54:157–167
Functional alterations in vitiligo skin
High levels of TNF-alpha and FasL in the depigmented epidermis (role in increasing apoptosis) – Kim NH, et al. J Invest Dermatol 2007;127:2612–7.
mRNA for TNF-α and IL-6, with an inhibitory effect on pigmentation, was increased in the epidermis from vitiligo biopsies.
This could contribute to keratinocyte apoptosis, which results in reduced release of melanogenic cytokines and in melanocyte disappearance. – Moretti S, et al. Histol Histopathol 2009:24:849-857
Functional alterations in vitiligo skin
Apoptotic keratinocytes may cause a decrease in SCF synthesis, which plays an important role in melanocyte survival and proliferation
Keratinocyte apoptosis induces a decrease in the synthesis of other melanocyte growth factors, such as bFGF, resulting in melanocyte disappearance. – Lee AY, et al. Br J Dermatol
2004;151:995–1003.
– Moretti S, et al. Histol Histopathol
2009:24:849-857
Functional alterations in vitiligo skin
Endothelin-1 (ET-1) mRNA seems to be significantly reduced in lesional as compared to perilesional epidermis
SCF and ET-1 may contribute to melanocyte survival – Moretti S, et al. Histol Histopathol 2009:24:849-857
Functional alterations in vitiligo skin
Protease-activated receptor (PARs) 2 is abundantly expressed by keratinocytes, and seems to contribute to the pigmentation process
PAR-2 impairment is seen in vitiligo, and may contribute to the epidermal pigment deficit through a reduced melanosome uptake in keratinocytes.
To date, a precise cause and effect relationship between these two conditions cannot be determined. – Moretti S, et al. Pigment Cell Melanoma Res 2009;22:335–338
OUR CONTRIBUTIONS
Berti S, Bellandi S, Bertelli A, Colucci R, Lotti T, Moretti S. Vitiligo
in an Italian outpatient center: a clinical and serologic study of 204
patients in Tuscany. Am J Clin Dermatol. 2011;12(1):43-9.
Prignano F, Ricceri F, Bianchi B, Guasti D, Bonciolini V, Lotti T,
Pimpinelli N. Dendritic cells: ultrastructural and
immunophenotypical changes upon nb-UVB in vitiligo skin. Arch
Dermatol Res. 2010
Arunachalam M, Sanzo M, Lotti T, Colucci R, Berti S, Moretti S.
Common variable immunodeficiency in vitiligo. G Ital Dermatol
Venereol. 2010;145(6):783-8.
Becatti M, Prignano F, Fiorillo C, Pescitelli L, Nassi P, Lotti T, Taddei
N. The involvement of Smac/DIABLO, p53, NF-kB, and MAPK
pathways in apoptosis of keratinocytes from perilesional vitiligo
skin: Protective effects of curcumin and capsaicin. Antioxid Redox
Signal. 2010, 1;13(9):1309-1321.
Prignano F, Pescitelli L, Becatti M, Di Gennaro P, Fiorillo C, Taddei
N, Lotti T. Ultrastructural and functional alterations of mitochondria
in perilesional vitiligo skin. J Derm Sci 2009;54:157–167;
Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, Nassini R,
Lotti T and Massi D. Keratinocyte dysfunction in vitiligo epidermis:
cytokine microenvironment and correlation to keratinocyte
apoptosis. Histol Histopathol 2009;24:849-857;
Moretti S, Nassini R, Prignano F, Pacini A, Materazzi S, Naldini A,
Simoni A, Baroni G, Pellerito S, Filippi I, Lotti T, Geppetti P and Massi
D. Protease-activated receptor-2 downregulation is associated to
vitiligo lesions. Pigment Cell Melanoma Res. 2009;22:335–338.
Prignano F, Pescitelli L, Ricceri F, Lotti T. The importance of genetical link
in immuno-mediated dermatoses: psoriasis and vitiligo. Int J Dermatol
2008;47:1060–1062;
Prignano F, Betts CM, Lotti T. Vogt-Koyanagi-Harada disease and vitiligo:
where does the illness begin? J Electron Microsc (Tokyo). 2008
Thank you for your attention